Literature DB >> 20013315

Morphine and rapid disease progression in nonhuman primate model of AIDS: inverse correlation between disease progression and virus evolution.

Vanessa Rivera-Amill1, Peter S Silverstein, Richard J Noel, Santosh Kumar, Anil Kumar.   

Abstract

HIV and simian immunodeficiency virus (SIV) have a formidable capacity for mutation and adaptation, a characteristic that has contributed to the extensive genetic variability. Evolutionary pressures imposed within the host and the viral capacity to mutate lead to the generation of such variants. To date, very little information is available regarding the evolution of HIV with drug abuse as a cofounding factor. Using our macaque model of drug dependency and AIDS, we have investigated the dynamics of SIV mutations in the genes tat, vpr, envelope, and nef. The results presented in this review, from our laboratory and others, contribute to the overall understanding of how drugs of abuse might influence immune selective pressure contribution to variation in different SIV genes. Additionally, the studies presented could help enlighten the development of HIV vaccines that take into consideration viral diversity.

Entities:  

Mesh:

Year:  2009        PMID: 20013315      PMCID: PMC4095870          DOI: 10.1007/s11481-009-9184-0

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  92 in total

1.  Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell.

Authors:  Timothy B Saurer; Kelly A Carrigan; Stephanie G Ijames; Donald T Lysle
Journal:  J Neuroimmunol       Date:  2005-12-20       Impact factor: 3.478

2.  Evolution of SIV envelope in morphine-dependent rhesus macaques with rapid disease progression.

Authors:  Grissell Tirado; Anil Kumar
Journal:  AIDS Res Hum Retroviruses       Date:  2006-01       Impact factor: 2.205

3.  Morphine impairs host innate immune response and increases susceptibility to Streptococcus pneumoniae lung infection.

Authors:  Jinghua Wang; Roderick A Barke; Richard Charboneau; Sabita Roy
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

4.  HIV-1 gp120-induced TNF-{alpha} production by primary human macrophages is mediated by phosphatidylinositol-3 (PI-3) kinase and mitogen-activated protein (MAP) kinase pathways.

Authors:  Chuhee Lee; Brian Tomkowicz; Bruce D Freedman; Ronald G Collman
Journal:  J Leukoc Biol       Date:  2005-08-04       Impact factor: 4.962

5.  Correlation between SIV Tat evolution and AIDS progression in cerebrospinal fluid of morphine-dependent and control macaques infected with SIV and SHIV.

Authors:  Richard J Noel; Ziomara Marrero-Otero; Rakesh Kumar; Gladys S Chompre-González; Ashish S Verma; Anil Kumar
Journal:  Virology       Date:  2006-04-27       Impact factor: 3.616

Review 6.  Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat.

Authors:  J Rappaport; J Joseph; S Croul; G Alexander; L Del Valle; S Amini; K Khalili
Journal:  J Leukoc Biol       Date:  1999-04       Impact factor: 4.962

Review 7.  The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations.

Authors:  Farzana Kapadia; David Vlahov; Robert M Donahoe; Gerald Friedland
Journal:  Clin Infect Dis       Date:  2005-08-22       Impact factor: 9.079

8.  Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia.

Authors:  Kimberly Ritola; Kevin Robertson; Susan A Fiscus; Colin Hall; Ronald Swanstrom
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

9.  Virus replication and disease progression inversely correlate with SIV tat evolution in morphine-dependent and SIV/SHIV-infected Indian rhesus macaques.

Authors:  Richard J Noel; Anil Kumar
Journal:  Virology       Date:  2005-11-28       Impact factor: 3.616

10.  Longitudinal analysis of nef/long terminal repeat-deleted HIV-1 in blood and cerebrospinal fluid of a long-term survivor who developed HIV-associated dementia.

Authors:  Melissa Churchill; Jasminka Sterjovski; Lachlan Gray; Daniel Cowley; Catherine Chatfield; Jennifer Learmont; John S Sullivan; Suzanne M Crowe; John Mills; Bruce J Brew; Steven L Wesselingh; Dale A McPhee; Paul R Gorry
Journal:  J Infect Dis       Date:  2004-11-16       Impact factor: 5.226

View more
  13 in total

1.  Identification and molecular characterization of SIV Vpr R50G mutation associated with long term survival in SIV-infected morphine dependent and control macaques.

Authors:  Ivelisse Rivera; Yashira García; Mohitkumar R Gangwani; Richard J Noel; Lucianette Maldonado; Anil Kumar; Vanessa Rivera-Amill
Journal:  Virology       Date:  2013-08-28       Impact factor: 3.616

2.  Translational research in NeuroAIDS: a neuroimmune pharmacology-related course.

Authors:  Amanda Brown; Bruce Shiramizu; Avindra Nath; Valerie Wojna
Journal:  J Neuroimmune Pharmacol       Date:  2010-05-25       Impact factor: 4.147

3.  An infectious murine model for studying the systemic effects of opioids on early HIV pathogenesis in the gut.

Authors:  Gregory M Sindberg; Umakant Sharma; Santanu Banerjee; Vidhu Anand; Raini Dutta; Chao-Jiang Gu; David J Volsky; Sabita Roy
Journal:  J Neuroimmune Pharmacol       Date:  2014-12-12       Impact factor: 4.147

4.  Therapeutical Neurotargeting via Magnetic Nanocarrier: Implications to Opiate-Induced Neuropathogenesis and NeuroAIDS.

Authors:  Vidya Sagar; Sudheesh Pilakka-Kanthikeel; Venkata S R Atluri; Hong Ding; Adriana Y Arias; Rahul D Jayant; Ajeet Kaushik; Madhavan Nair
Journal:  J Biomed Nanotechnol       Date:  2015-10       Impact factor: 4.099

5.  Morphine produces immunosuppressive effects in nonhuman primates at the proteomic and cellular levels.

Authors:  Joseph N Brown; Gabriel M Ortiz; Thomas E Angel; Jon M Jacobs; Marina Gritsenko; Eric Y Chan; David E Purdy; Robert D Murnane; Kay Larsen; Robert E Palermo; Anil K Shukla; Theresa R Clauss; Michael G Katze; Joseph M McCune; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2012-05-11       Impact factor: 5.911

6.  Morphine Potentiates Dysbiotic Microbial and Metabolic Shifts in Acute SIV Infection.

Authors:  Gregory M Sindberg; Shannon E Callen; Santanu Banerjee; Jingjing Meng; Vanessa L Hale; Ramakrishna Hegde; Paul D Cheney; Francois Villinger; Sabita Roy; Shilpa Buch
Journal:  J Neuroimmune Pharmacol       Date:  2018-09-21       Impact factor: 4.147

7.  Damage of splenic T lymphocyte proliferation and differentiation and its normalization by electroacupuncture in morphine-dependent mice mode.

Authors:  Hong-Yu Li; Rong Zhang; Cai-Lian Cui; Ji-Sheng Han; Liu-Zhen Wu
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-09       Impact factor: 2.629

8.  Interactive Effects of Morphine on HIV Infection: Role in HIV-Associated Neurocognitive Disorder.

Authors:  Pichili Vijaya Bhaskar Reddy; Sudheesh Pilakka-Kanthikeel; Shailendra K Saxena; Zainulabedin Saiyed; Madhavan P N Nair
Journal:  AIDS Res Treat       Date:  2012-05-20

Review 9.  Disruption of gut homeostasis by opioids accelerates HIV disease progression.

Authors:  Jingjing Meng; Gregory M Sindberg; Sabita Roy
Journal:  Front Microbiol       Date:  2015-06-26       Impact factor: 5.640

10.  Injecting drug use is associated with a more rapid CD4 cell decline among treatment naïve HIV-positive patients in Indonesia.

Authors:  Hinta Meijerink; Rudi Wisaksana; Shelly Iskandar; Martin den Heijer; Andre J A M van der Ven; Bachti Alisjahbana; Reinout van Crevel
Journal:  J Int AIDS Soc       Date:  2014-01-03       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.